Abstract
The aim of this study was to assess whether thymidylate synthase (TYMS) genotype, serum homocysteine, and folate concentrations were related to venous thrombosis in Behçet's disease (BD) patients. The study included 104 BD patients fulfilling the International Study Group Criteria for the diagnosis of BD and 121 healthy individuals–controls. Out of 104 patients, 50 (48%) had vascular involvement: 34 had active–history of venous thrombosis, 16 had arterial involvement (aneurysm), and 11 of these patients had both venous and arterial lesions as confirmed by Doppler ultrasound and/or angiography. Genotype analysis of the TYMS promoter enhancer region was determined by polymerase chain reaction. The distribution of the TYMS genotypes 2R/2R, 2R/3R, 3R/3R, 4R/2R, and 3R/3R were not significantly different between BD patients and control group (p > 0.05; 16.5% vs 8.3%, 49.0% vs 53.9%, 31.7% vs 38.0%, 1.9% vs 0%, and 1.0% vs 0%, respectively). TYMS genotypes were not associated with thrombosis and serum homocysteine concentration in BD patients. The mean serum homocysteine level in patients with thrombosis (14.87 ± 8.99 μmol/L) was significantly higher than the level in patients without thrombosis (10.78 ± 3.81 μmol/L; p < 0.05). Serum folate concentrations were not different between the BD patients and the healthy controls. The study results suggest that the distribution TYMS genotype in BD was not different from that of healthy controls. There was no relationship between TYMS genotype and the homocysteine levels in BD patients with thrombosis or without thrombosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Behçet H (1937) Uber rezidiverende aphtose durch ein virus verurschte Geschwure am Mund, am Auge, und an den genitalien. Dermatol Wochenschr 105:1152–1157
Leiba M, Sidi Y, Gür H et al (2001) Behçet's disease and thrombophilia. Ann Rheum Dis 60:1081–1085
Selhub J, Jacques PF, Wilson PWF et al (1993) Vitamin status and mistake and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698
Tawakal A, Omland T, Gerhard M et al (1997) Hyperhomocysteinemia is associated with impaired endothelium-dependant vasodilation in humans. Circulation 995:1119–1121
Perry IJ, Refsum H, Morris RW et al (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395–1398
Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315–323
den Heijer M, Koster T, Blomm HJ et al (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Eng J Med 334:759–762
Ateş A, Aydıntuğ O, Ölmez Ü et al (2005) Serum homocysteine level is higher in Behçet’s disease with vascular involvement. Rheumatol Int 25:42–44
Canataroglu A, Tanriverdi K, Inal T et al (2003) Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease. Rheumatol Int 23(5):236–240
Yeşilova Z, Pay S, Oktenli C et al (2005) Hyperhomocysteinemia in patients with Behçet’s disease: is it due to inflammation or therapy. Rheumatol Int 25:423–428
Aksu K, Turgan N, Oksel F (2001) Hyperhomocysteinemia in Behçet’s disease. Rheumatology 40:687–690
Nalbant S, Aktay D, Cingozbay Y (2003) Homocysteine and Behçet disease. J Clin Rheumatol 9:65–66
Lee YJ, Kang SW, Yang JI et al (2002) Coagulation parameters and plasma total homocysteine levels in Behçet’s disease. Thromb Res 106:19–24
Feki M, Houman H, Ghannouchi M et al (2004) Hyperhomocysteinemia is associated with uveitis but not with deep venous thrombosis in Behçet’s disease. Clin Chem Lab Med 42(12):141–123
Trinh BN, Ong CN, Gerhard A et al (2002) Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111:299–302
Liu J, Schmitz JC, Lin X et al (2002) Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta 1587:174–182
Ulrich CM, Bigler J, Bostick R (2002) Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Research 62:3361–3364
Ma Ricart J, Vaya A, Todoli J et al (2006) Thrombophilic risk factors and homocysteine levels in Behçet’s disease in Eastern Spain and their association with thrombotic events. Thromb Haemost 95(4):618–624
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215
Ulrich C, Bigler J, Velicer C et al (2000) Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol. Biomark Prev 9:1381–1385
Suzen HS, Yüce N, Güvenç G et al (2005) TYMS and DPYD polymorphisms in a Turkish population. Eur J Clin Pharmacol 61(12):881–885
Brown KS, Kluijtmans LA, Young IS et al (2004) The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects. Hum Genet 114(2):182–185
Seyahi E, Yazici H (2007) Atherosclerosis in Behçet’s syndrome. Clin Exp Rheumatol 25(4 Supp 45):1–5
Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113
Acknowledgement
This study was supported by the Ankara University Scientific Research Fund (2004 08 09192).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Düzgün, N., Duman, T., Morris, Y. et al. Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet’s disease. Clin Rheumatol 27, 1221–1225 (2008). https://doi.org/10.1007/s10067-008-0889-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-0889-x